Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 13476

1.

Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.

Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.

Vaccine. 2015 Jan 24. pii: S0264-410X(15)00088-2. doi: 10.1016/j.vaccine.2015.01.044. [Epub ahead of print]

PMID:
25625671
[PubMed - as supplied by publisher]
2.

Neurologic manifestations of the neglected tropical diseases.

Berkowitz AL, Raibagkar P, Pritt BS, Mateen FJ.

J Neurol Sci. 2015 Jan 9. pii: S0022-510X(15)00002-7. doi: 10.1016/j.jns.2015.01.001. [Epub ahead of print] Review.

PMID:
25623803
[PubMed - as supplied by publisher]
3.

Role of Δ1-Pyrroline-5-Carboxylate-dehydrogenase supports mitochondrial metabolism and host-cell invasion of Trypanosoma cruzi.

Mantilla BS, Paes LS, Pral EM, Martil DE, Thiemann OH, Fernández-Silva P, Bastos EL, Silber AM.

J Biol Chem. 2015 Jan 26. pii: jbc.M114.574525. [Epub ahead of print]

PMID:
25623067
[PubMed - as supplied by publisher]
4.

Conditional removal of selectable markers in Trypanosoma cruzi using a site-specific recombination tool: proof of concept.

Kangussu-Marcolino MM, Cunha AP, Avila AR, Herman JP, DaRocha WD.

Mol Biochem Parasitol. 2015 Jan 22. pii: S0166-6851(15)00002-X. doi: 10.1016/j.molbiopara.2015.01.001. [Epub ahead of print]

PMID:
25619800
[PubMed - as supplied by publisher]
5.

A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Re-programs Immune Response and Reverses Chronic Cardiomyopathy.

Pereira IR, Vilar-Pereira G, Marques V, da Silva AA, Caetano B, Moreira OC, Machado AV, Bruna-Romero O, Rodrigues MM, Gazzinelli RT, Lannes-Vieira J.

PLoS Pathog. 2015 Jan 24;11(1):e1004594. doi: 10.1371/journal.ppat.1004594. eCollection 2015 Jan.

PMID:
25617628
[PubMed - in process]
Free Article
6.

Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation.

Clarke JR, Lyra E Silva NM, Figueiredo CP, Frozza RL, Ledo JH, Beckman D, Katashima CK, Razolli D, Carvalho BM, Frazão R, Silveira MA, Ribeiro FC, Bomfim TR, Neves FS, Klein WL, Medeiros R, LaFerla FM, Carvalheira JB, Saad MJ, Munoz DP, Velloso LA, Ferreira ST, De Felice FG.

EMBO Mol Med. 2015 Jan 23. pii: e201404183. doi: 10.15252/emmm.201404183. [Epub ahead of print]

PMID:
25617315
[PubMed - as supplied by publisher]
Free Article
7.

Is the increased presence of cd8 t-lymphocytes related to serotonin levels in chagas' disease?

Jabari S, Brehmer A, de Oliveira EC, de Oliveira FC, de Freitas MA, da Silveira AB.

Colorectal Dis. 2015 Jan 23. doi: 10.1111/codi.12907. [Epub ahead of print]

PMID:
25616063
[PubMed - as supplied by publisher]
8.

Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line.

Alonso-Padilla J, Cotillo I, Presa JL, Cantizani J, Peña I, Bardera AI, Martín JJ, Rodriguez A.

PLoS Negl Trop Dis. 2015 Jan 23;9(1):e0003493. doi: 10.1371/journal.pntd.0003493. eCollection 2015 Jan.

PMID:
25615687
[PubMed - in process]
Free Article
9.

The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma Cruzi infection in CD-1 mice.

Brima W, Eden DJ, Mehdi SF, Bravo M, Wiese MM, Stein J, Almonte V, Zhao D, Kurland I, Pessin JE, Zima T, Tanowitz HB, Weiss LM, Roth J, Nagajyothi F.

Diabetes Metab Res Rev. 2015 Jan 22. doi: 10.1002/dmrr.2636. [Epub ahead of print]

PMID:
25613819
[PubMed - as supplied by publisher]
10.

Immunoregulatory actions of melatonin and zinc during chronic Trypanosoma cruzi infection.

Brazão V, Santello FH, Filipin MD, Azevedo AP, Toldo MP, de Morais FR, Prado JC Jr.

J Pineal Res. 2015 Jan 22. doi: 10.1111/jpi.12207. [Epub ahead of print]

PMID:
25611919
[PubMed - as supplied by publisher]
11.

Response to letter to the editor regarding article "repolarization parameters are associated with mortality in chagas disease patients in the United States".

Bradfield J, Woodbury B, Traina M, Hernandez S, Sanchez D, Wachsner R, Shivkumar K, Meymandi S.

Indian Pacing Electrophysiol J. 2014 Dec 15;14(6):311-2. eCollection 2014 Nov-Dec. No abstract available.

PMID:
25609901
[PubMed]
Free PMC Article
12.

Fragmented QRS and Chagas' disease.

Baranchuk A.

Indian Pacing Electrophysiol J. 2014 Dec 15;14(6):309-10. eCollection 2014 Nov-Dec. No abstract available.

PMID:
25609900
[PubMed]
Free PMC Article
13.

Development of a community-based intervention for the control of Chagas disease based on peridomestic animal management: an eco-bio-social perspective.

De Urioste-Stone SM, Pennington PM, Pellecer E, Aguilar TM, Samayoa G, Perdomo HD, Enríquez H, Juárez JG.

Trans R Soc Trop Med Hyg. 2015 Feb;109(2):159-67. doi: 10.1093/trstmh/tru202.

PMID:
25604767
[PubMed - in process]
14.

Experimental control of Triatoma infestans in poor rural villages of Bolivia through community participation.

Lardeux F, Depickère S, Aliaga C, Chavez T, Zambrana L.

Trans R Soc Trop Med Hyg. 2015 Feb;109(2):150-8. doi: 10.1093/trstmh/tru205.

PMID:
25604766
[PubMed - in process]
15.

An innovative ecohealth intervention for Chagas disease vector control in Yucatan, Mexico.

Waleckx E, Camara-Mejia J, Ramirez-Sierra MJ, Cruz-Chan V, Rosado-Vallado M, Vazquez-Narvaez S, Najera-Vazquez R, Gourbière S, Dumonteil E.

Trans R Soc Trop Med Hyg. 2015 Feb;109(2):143-9. doi: 10.1093/trstmh/tru200.

PMID:
25604765
[PubMed - in process]
16.

Eco-bio-social research on community-based approaches for Chagas disease vector control in Latin America.

Gürtler RE, Yadon ZE.

Trans R Soc Trop Med Hyg. 2015 Feb;109(2):91-98. Review.

PMID:
25604759
[PubMed - as supplied by publisher]
17.

Innovative community-based ecosystem management for dengue and Chagas disease prevention in low and middle income countries in Latin America and the Caribbean.

Finkelman J.

Trans R Soc Trop Med Hyg. 2015 Feb;109(2):89-90. doi: 10.1093/trstmh/tru201.

PMID:
25604758
[PubMed - in process]
18.

Innovative community-based vector control interventions for improved dengue and Chagas disease prevention in Latin America: introduction to the special issue.

Sommerfeld J, Kroeger A.

Trans R Soc Trop Med Hyg. 2015 Feb;109(2):85-8. doi: 10.1093/trstmh/tru176. No abstract available.

PMID:
25604757
[PubMed - in process]
19.

Immunomodulatory properties and anti-apoptotic effects of zinc and melatonin in an experimental model of chronic Chagas disease.

Brazão V, Filipin MD, Santello FH, Azevedo AP, Toldo MP, de Morais FR, do Prado JC Jr.

Immunobiology. 2015 Jan 9. pii: S0171-2985(14)00264-2. doi: 10.1016/j.imbio.2014.11.018. [Epub ahead of print]

PMID:
25604665
[PubMed - as supplied by publisher]
20.

Dynamics of CYP51: implications for function and inhibitor design.

Yu X, Cojocaru V, Mustafa G, Salo-Ahen OM, Lepesheva GI, Wade RC.

J Mol Recognit. 2015 Feb;28(2):59-73. doi: 10.1002/jmr.2412. Epub 2015 Jan 20.

PMID:
25601796
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk